Metropolis Healthcare has approved the issuance of bonus equity shares at a ratio of 3:1, marking a significant corporate action for the healthcare diagnostics company.

Bonus Share Details

The approved bonus issue will provide shareholders with substantial additional equity holdings in the company.

Impact on Shareholders

Under this bonus share scheme, existing shareholders will receive three additional equity shares for every one share they currently hold. This corporate action will increase the total number of shares outstanding while maintaining the proportional ownership structure for all shareholders.

The bonus issue represents a method of rewarding shareholders by capitalizing reserves and distributing additional shares without requiring any payment from investors. This action typically makes shares more affordable and accessible to a broader range of investors while maintaining the overall market capitalization of the company.

Metropolis healthcare has completed the allotment of equity shares to employees under its employee stock compensation program. The Nomination and Remuneration Committee approved the allotment through a circular resolution dated January 13, 2026, demonstrating the company's commitment to employee incentivization through equity participation.

Share Allotment Details

The allotment encompasses 9,960 equity shares issued under the Metropolis Restrictive Stock Unit Plan 2020. The key parameters of this allotment are presented below:

Post-Allotment Capital Structure

Following this equity allotment, the company's capital structure has been updated accordingly. The distinctive numbers for the newly allotted shares range from 5,18,21,983 to 5,18,31,942 (both inclusive).

Lock-in Provisions and Share Rights

The allotted equity shares are subject to specific lock-in arrangements designed to ensure employee retention and alignment with company objectives. Under the terms of the MHL-RSU Plan 2020:

• 50% of the equity shares allotted to each RSU holder are subject to lock-in restrictions
• The lock-in period extends for one year from the date of allotment
• Lock-in expiry date is set for January 13, 2027
• All newly allotted shares rank pari-passu with existing equity shares in all respects

Regulatory Compliance

The allotment has been conducted in full compliance with regulatory requirements under SEBI regulations. The company obtained necessary approvals from both BSE Limited (Case No. 130335) and National Stock Exchange of India Ltd. (Application No. 27089). The original filing for the employee benefits scheme was completed on May 23, 2021, with in-principle approvals received from both exchanges in June 2021.

The shares have been issued in dematerialized form and will be available for trading subject to the applicable lock-in provisions. The company has fulfilled all disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.